Romazicon is a brand name of flumazenil, approved by the FDA in the following formulation(s):
ROMAZICON (flumazenil - injectable; injection)
Manufacturer: HOFFMANN LA ROCHE
Approval date: December 20, 1991
Strength(s): 0.5MG/5ML (0.1MG/ML) [AP], 1MG/10ML (0.1MG/ML) [RLD][AP]
Has a generic version of Romazicon been approved?
Yes. The following products are equivalent to Romazicon:
flumazenil injectable; injection
Manufacturer: APP PHARMS
Approval date: October 12, 2004
Strength(s): 0.5MG/5ML (0.1MG/ML) [AP], 1MG/10ML (0.1MG/ML) [AP]
Manufacturer: BAXTER HLTHCARE
Approval date: October 12, 2004
Strength(s): 0.5MG/5ML (0.1MG/ML) [AP], 1MG/10ML (0.1MG/ML) [AP]
Manufacturer: BEDFORD LABS
Approval date: October 12, 2004
Strength(s): 0.5MG/5ML (0.1MG/ML) [AP], 1MG/10ML (0.1MG/ML) [AP]
Manufacturer: CLARIS LIFESCIENCES
Approval date: October 12, 2004
Strength(s): 0.5MG/5ML (0.1MG/ML) [AP], 1MG/10ML (0.1MG/ML) [AP]
Manufacturer: HIKMA FARMACEUTICA
Approval date: March 23, 2009
Strength(s): 0.5MG/5ML (0.1MG/ML) [AP], 1MG/10ML (0.1MG/ML) [AP]
Manufacturer: PFIZER
Approval date: May 13, 2008
Strength(s): 0.5MG/5ML (0.1MG/ML) [AP], 1MG/10ML (0.1MG/ML) [AP]
Manufacturer: SANDOZ
Approval date: May 3, 2005
Strength(s): 0.5MG/5ML (0.1MG/ML) [AP], 1MG/10ML (0.1MG/ML) [AP]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Romazicon. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Romazicon.
See also...
- Romazicon Consumer Information (Wolters Kluwer)
- Romazicon Consumer Information (Cerner Multum)
- Romazicon AHFS DI Monographs (ASHP)
- Flumazenil Consumer Information (Wolters Kluwer)
- Flumazenil Consumer Information (Cerner Multum)
- Flumazenil AHFS DI Monographs (ASHP)
No comments:
Post a Comment